Download PDF
Semin Thromb Hemost 2022; 48(03): 338-343
DOI: 10.1055/s-0041-1735897
Review Article

Nonhematologic and Hematologic Factors in Spontaneous Intracerebral Hemorrhage

Hau C. Kwaan
1   Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Spontaneous intracerebral hemorrhage is defined as nontraumatic bleeding into the brain without vascular malformations or presence of tumor. It occurs in about a third of all strokes and has a high mortality and morbidity. Risk factors that determine the outcome are incompletely understood. Known factors include older age, male gender, Asian ethnicity, hypertension, and comorbidity such as inherited or acquired bleeding diathesis and use of antithrombotic drugs. Likewise, the clinical characteristics of the hematoma such as location and volume of the hematoma and other imaging features are also important. Hematoma extension or expansion is a complication with an unfavorable outcome. Recognition of risk factors for hematoma expansion and measures to prevent it, such as blood pressure lowering, will improve the outcome. Enhanced diagnostic methods, especially in imaging techniques developed over the past decade, have not only led to a better understanding of the pathophysiology of spontaneous intracerebral hemorrhage but also of the factors that influence hematoma expansion. An improved knowledge is essential to better management, minimizing hematoma expansion and leading to a healthier outcome.

Keywords

intracerebral hemorrhage - hematoma expansion - hypertension - biomarkers - platelet function


Publication History

Article published online:
13 October 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344 (19) 1450-1460
    CrossrefPubMedGoogle Scholar
  • 2 Rychen J, O'Neill A, Lai LT, Bervini D. Natural history and surgical management of spontaneous intracerebral hemorrhage: a systematic review. J Neurosurg Sci 2020; 64 (06) 558-570
    PubMedGoogle Scholar
  • 3 Garg R, Biller J. Recent advances in spontaneous intracerebral hemorrhage. F1000Res 2019; 8: F1000 Faculty Rev-302
    CrossrefPubMedGoogle Scholar
  • 4 An SJ, Kim TJ, Yoon BW. Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update. J Stroke 2017; 19 (01) 3-10
    CrossrefPubMedGoogle Scholar
  • 5 van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010; 9 (02) 167-176
    CrossrefPubMedGoogle Scholar
  • 6 Broderick J, Connolly S, Feldmann E. et al; American Heart Association/American Stroke Association Stroke Council, American Heart Association/American Stroke Association High Blood Pressure Research Council, Quality of Care and Outcomes in Research Interdisciplinary Working Group. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007; 116 (16) e391-e413
    CrossrefPubMedGoogle Scholar
  • 7 Naidech AM. Diagnosis and management of spontaneous intracerebral hemorrhage. Continuum (Minneap Minn) 2015; 21 (5 Neurocritical Care): 1288-1298
    PubMedGoogle Scholar
  • 8 Elliott J, Smith M. The acute management of intracerebral hemorrhage: a clinical review. Anesth Analg 2010; 110 (05) 1419-1427
    CrossrefPubMedGoogle Scholar
  • 9 Broderick JP, Brott T, Tomsick T, Miller R, Huster G. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993; 78 (02) 188-191
    CrossrefPubMedGoogle Scholar
  • 10 Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24 (07) 987-993
    CrossrefPubMedGoogle Scholar
  • 11 Brott T, Broderick JP. Intracerebral hemorrhage. Heart Dis Stroke 1993; 2 (01) 59-63
    PubMedGoogle Scholar
  • 12 Jolink WM, Klijn CJ, Brouwers PJ, Kappelle LJ, Vaartjes I. Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage. Neurology 2015; 85 (15) 1318-1324
    CrossrefPubMedGoogle Scholar
  • 13 Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 1986; 17 (06) 1078-1083
    CrossrefPubMedGoogle Scholar
  • 14 Andalib S, Lattanzi S, Di Napoli M. et al. Blood pressure variability: a new predicting factor for clinical outcomes of intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2020; 29 (12) 105340
    CrossrefPubMedGoogle Scholar
  • 15 Caceres JA, Goldstein JN. Intracranial hemorrhage. Emerg Med Clin North Am 2012; 30 (03) 771-794
    CrossrefPubMedGoogle Scholar
  • 16 Wieberdink RG, Poels MM, Vernooij MW. et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol 2011; 31 (12) 2982-2989
    CrossrefPubMedGoogle Scholar
  • 17 Biffi A, Sonni A, Anderson CD. et al; International Stroke Genetics Consortium. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 2010; 68 (06) 934-943
    CrossrefPubMedGoogle Scholar
  • 18 Tsai HH, Pasi M, Tsai LK. et al. Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: a PiB-PET study. Neurology 2019; 92 (08) e774-e781
    CrossrefPubMedGoogle Scholar
  • 19 Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9 (07) 689-701
    CrossrefPubMedGoogle Scholar
  • 20 Hines K, Mouchtouris N, Al Saiegh F. et al. Prediction of hematoma expansion in spontaneous intracerebral hemorrhage: our institutional experience. J Clin Neurosci 2021; 86: 271-275
    CrossrefPubMedGoogle Scholar
  • 21 Chai-Adisaksopha C, Crowther M, Isayama T, Lim W. The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Blood 2014; 124 (15) 2450-2458
    CrossrefPubMedGoogle Scholar
  • 22 Seiffge DJ, Goeldlin MB, Tatlisumak T. et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol 2019; 266 (12) 3126-3135
    CrossrefPubMedGoogle Scholar
  • 23 Whiteley WN, Emberson J, Lees KR. et al; Stroke Thrombolysis Trialists' Collaboration. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. Lancet Neurol 2016; 15 (09) 925-933
    CrossrefPubMedGoogle Scholar
  • 24 Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 2003; 112 (10) 1533-1540
    CrossrefPubMedGoogle Scholar
  • 25 Paterson PY, Gausas J, Koh CS, Kwaan HC. The clotting system: gatekeeper of cerebrovascular permeability and monitor of clinical manifestations of neuroautoimmune disease. Trans Am Clin Climatol Assoc 1986; 97: 149-157
    PubMedGoogle Scholar
  • 26 Koh CS, Kwaan HC, Paterson PY. Neurovascular fibrinolytic activity in normal Lewis rats and rats with cell-transferred experimental allergic encephalomyelitis. J Neuroimmunol 1990; 28 (03) 189-200
    CrossrefPubMedGoogle Scholar
  • 27 Kwaan HC, Wang J, Weiss I. Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin. J Thromb Haemost 2004; 2 (02) 306-312
    CrossrefPubMedGoogle Scholar
  • 28 Su EJ, Fredriksson L, Geyer M. et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 2008; 14 (07) 731-737
    CrossrefPubMedGoogle Scholar
  • 29 Su EJ, Cao C, Fredriksson L. et al. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke. Acta Neuropathol 2017; 134 (04) 585-604
    CrossrefPubMedGoogle Scholar
  • 30 Lewandowski SA, Fredriksson L, Lawrence DA, Eriksson U. Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders. Pharmacol Ther 2016; 167: 108-119
    CrossrefPubMedGoogle Scholar
  • 31 Mateen FJ, Muralidharan R, Shinohara RT, Parisi JE, Schears GJ, Wijdicks EF. Neurological injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol 2011; 68 (12) 1543-1549
    CrossrefPubMedGoogle Scholar
  • 32 Cavayas YA, Del Sorbo L, Fan E. Intracranial hemorrhage in adults on ECMO. Perfusion 2018; 33 (1_suppl): 42-50
    CrossrefPubMedGoogle Scholar
  • 33 Cavayas YA, Del Sorbo L, Fan E. Intracranial hemorrhage in adults on ECMO. Perfusion 2018; 33 (1_suppl, suppl): 42-50
    CrossrefPubMedGoogle Scholar
  • 34 Lorusso R, Centofanti P, Gelsomino S. et al; GIROC Investigators. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience. Ann Thorac Surg 2016; 101 (03) 919-926
    CrossrefPubMedGoogle Scholar
  • 35 Klinzing S, Wenger U, Stretti F. et al. Neurologic injury with severe adult respiratory distress syndrome in patients undergoing extracorporeal membrane oxygenation: a single-center retrospective analysis. Anesth Analg 2017; 125 (05) 1544-1548
    CrossrefPubMedGoogle Scholar
  • 36 Fletcher-Sandersjöö A, Thelin EP, Bartek Jr J. et al. Incidence, outcome, and predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: a systematic and narrative review. Front Neurol 2018; 9: 548
    CrossrefPubMedGoogle Scholar
  • 37 Grover SP, Mackman N. Tissue factor: an essential mediator of hemostasis and trigger of thrombosis. Arterioscler Thromb Vasc Biol 2018; 38 (04) 709-725
    CrossrefPubMedGoogle Scholar
  • 38 Johansson K, Jansson JH, Johansson L, Wiklund PG, Nilsson TK, Lind M. D-dimer is associated with first-ever intracerebral hemorrhage. Stroke 2018; 49 (09) 2034-2039
    CrossrefPubMedGoogle Scholar
  • 39 Zhou Q, Zhang D, Chen X. et al. Plasma D-dimer predicts poor outcome and mortality after spontaneous intracerebral hemorrhage. Brain Behav 2021; 11 (01) 462-468
    CrossrefPubMedGoogle Scholar
  • 40 Lauridsen SV, Hvas AM, Sandgaard E. et al. Coagulation profile after spontaneous intracerebral hemorrhage: a cohort study. J Stroke Cerebrovasc Dis 2018; 27 (11) 2951-2961
    CrossrefPubMedGoogle Scholar
  • 41 Prodan CIVA, Vincent AS, Dale GL. Coated platelet levels correlate with bleed volume in patients with spontaneous intracerebral hemorrhage. Stroke 2010; 41 (06) 1301-1303
    CrossrefPubMedGoogle Scholar
  • 42 Lin CY, Chang CY, Sun CH. et al. Platelet count and early outcome in patients with spontaneous cerebellar hemorrhage: a retrospective study. PLoS One 2015; 10 (03) e0119109
    CrossrefPubMedGoogle Scholar
  • 43 Naidech AM, Jovanovic B, Liebling S. et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke 2009; 40 (07) 2398-2401
    CrossrefPubMedGoogle Scholar
  • 44 Naidech AM, Bernstein RA, Levasseur K. et al. Platelet activity and outcome after intracerebral hemorrhage. Ann Neurol 2009; 65 (03) 352-356
    CrossrefPubMedGoogle Scholar
  • 45 Baharoglu MI, Cordonnier C, Al-Shahi Salman R. et al; PATCH Investigators. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 2016; 387 (10038): 2605-2613
    CrossrefPubMedGoogle Scholar
  • 46 Naidech AM, Maas MB, Levasseur-Franklin KE. et al. Desmopressin improves platelet activity in acute intracerebral hemorrhage. Stroke 2014; 45 (08) 2451-2453
    CrossrefPubMedGoogle Scholar
  • 47 Andersen LK, Hvas AM, Hvas CL. Effect of desmopressin on platelet dysfunction during antiplatelet therapy: a systematic review. Neurocrit Care 2021; 34 (03) 1026-1046
    CrossrefPubMedGoogle Scholar
  • 48 Lauridsen SV, Hvas CL, Sandgaard E, Gyldenholm T, Tønnesen EK, Hvas AM. No hyperfibrinolysis following subarachnoid or intracerebral haemorrhage: a prospective cohort study. Blood Coagul Fibrinolysis 2019; 30 (07) 341-349
    CrossrefPubMedGoogle Scholar
  • 49 Wartenberg KE, Mayer SA. Wartenberger KaM. Ultra-early hemostatic therapy for intracerebral hemorrhage: future directions. Front Neurol Neurosci 2015; 37: 107-129
    CrossrefPubMedGoogle Scholar
  • 50 Anderson CS, Chalmers J, Stapf C. Blood-pressure lowering in acute intracerebral hemorrhage. N Engl J Med 2013; 369 (13) 1274-1275
    PubMedGoogle Scholar
  • 51 Anderson CS, Heeley E, Huang Y. et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013; 368 (25) 2355-2365
    CrossrefPubMedGoogle Scholar
  • 52 Hemphill III JC, Greenberg SM, Anderson CS. et al; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals From the American Heart Association/American Stroke Association. Stroke 2015; 46 (07) 2032-2060
    CrossrefPubMedGoogle Scholar